Abstract
Ultradeformable vesicles are liposomes made of phosphatidylcholine with a surfactant being included to impart the deformability. They were shown to enhance the transdermal delivery of drugs. The proposed mechanisms of their action include the possibility for vesicle adsorption, adhesion and may be fusion to the skin surface. This should provide intimate contact with the skin surface and may lead to direct vesicle-skin drug transfer. The possibility that intact vesicles can penetrate intact skin was also suggested with the transdermal hydration gradient being considered as the driving force for vesicle-skin penetration. This mechanism was said to be inhibited by occlusive application. The penetration-enhancing effect of the vesicle components was also suggested although its effect can be minor. Vesicle penetration into and through the hair follicles is another possibility. Accordingly, the aim of this chapter is to critically review the mechanisms of enhanced transdermal delivery from ultradeformable vesicles. The effect of application technique will be considered. Finally, the future perspectives will be highlighted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Artman C, Roding J, Ghyczy M, Prazel HG (1990a) Liposomes from soya phospholipids as percutaneous drug carriers: qualitative in vivo investigations with antibody-loaded liposomes. Arzneimittelforschung 40(II):1363–1365
Artman C, Roding J, Ghyczy M, Prazel HG (1990b) Liposomes from soya phospholipids as percutaneous drug carriers: quantitative in vivo investigations with radioactivity labelled liposomes. Arzneimittelforschung 40(II):1365–1368
Cevc G, Blume G (1992) Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1104:226–232
Cevc G, Gebauer D (2003) Hydration-driven transport of deformable lipid vesicles through fine pores and skin barrier. Biophys J 84:1010–1024
Cevc G, Schätzlein A, Blume G (1995) Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Release 36:3–16
Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G (1998) Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1368:201–215
Cevc G, Schätzlein A, Richardsen H (2002) Ultradeformable lipid vesicles can penetrate skin and other semi-permeable membrane barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement. Biochim Biophys Acta 1564:21–30
Egbaria K, Ramachandran C, Kittayanond D, Weiner N (1990) Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies. Antimicrob Agents Chemother 34(1):107–110
El Maghraby GM, Williams AC (2009) Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv 6:149–163
El Maghraby GM, Williams AC, Barry BW (1999) Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 51:1123–1134
El Maghraby GM, Williams AC, Barry BW (2000a) Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196:63–74
El Maghraby GM, Williams AC, Barry BW (2000b) Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204:159–169
El Maghraby GM, Williams AC, Barry BW (2001a) Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 53:1069–1077
El Maghraby GM, Williams AC, Barry BW (2001b) Skin hydration and possible shunt route penetration in controlled skin delivery of estradiol from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 53:1311–1322
El Maghraby GM, Williams AC, Barry BW (2006) Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol 58:415–429
El Maghraby GM, Williams AC, Barry BW (2008) Liposomes and skin. From drug delivery to model membranes. Eur J Pharm Sci 34:203–222
Foldvari M (1994) In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles. Pharm Res 11(11):1593–1598
Foldvari M, Gesztes A, Mezei M (1990) Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies. J Microencapsul 7(4):479–489
Ganesan MG, Weiner ND, Flynn GL, Ho NFH (1984) Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm 20:139–154
Gesztes A, Mezei M (1988) Topical anaesthesia of skin by liposome-encapsulated tetracaine. Aneth Analg 67:1079–1081
Han I, Kim M, Kim J (2004) Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp Dermatol 13(2):86–92
Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74
Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA (2003) The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release 90(2):243–255
Honeywell-Nguyen PL, Gooris GS, Bouwstra JA (2004) Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 123(5):902–910
Jung S, Otberg N, Thiede G, Richter H, Sterry W, Panzner S, Lademann J (2006) Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 126:1728–1732
Kirjavainen M, Urtti A, Jaaskelainen I, Suhonen TM, Paronen P, Koskela RV, Kiesvaara J, Monkkonen J (1996) Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Biochim Biophys Acta 1304:179–189
Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A (2009) Follicular transport route–research progress and future perspectives. Eur J Pharm Biopharm 71:173–180
Korting HC, Zeinicke H, Schafer KM, Falco OB (1990) Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 39:349–351
Korting HC, Stolz W, Schmid MH, Maierhofer G (1995) Interaction of liposomes with human epidermis constructed in vitro. British J Dermatol 132:571–579
Mezei M, Gulasekharam V (1980) Liposomes-a selective drug delivery system for topical route of administration. 1. Lotion dosage form. Life Sci 26:1473–1477
Mezei M, Gulasekharam V (1982) Liposomes-a selective drug delivery system for topical route of administration: gel dosage form. J Pharm Pharmacol 34:473–474
Mishra V, Mahor S, Rawat A, Dubey P, Gupta PN, Singh P, Vyas SP (2006) Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 24:5559–5570
Planas ME, Gonzalez P, Rodriguez L, Sanchez S, Cevc G (1992) Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Aneth Analg 75:615–621
Schaller M, Korting HC (1996) Interaction of liposomes with human skin: the role of the stratum corneum. Adv Drug Deliv Rev 18:303–309
Trotta M, Peira E, Debernardi F, Gallarate M (2002) Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241:319–327
Valenta C, Janisch M (2003) Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm 258:133–139
Verma DD, Verma S, Blume G, Fahr A (2003) Particle size of liposomes influences dermal delivery of substance into skin. Int J Pharm 258:141–151
Warner RR, Myers MC, Taylor DA (1988) Electron probe analysis of human skin: determination of the water concentration profile. J Invest Dermatol 90:218–224
Weiner N, Williams N, Birch G, Ramachandran C, Shipman CJR, Flynn G (1989) Topical delivery of liposomally encapsulated interferon evaluated in cutaneous herpes guinea pig model. Antimicrob Agents Chemother 33(8):1217–1221
Zellmer S, Pfeil W, Lasch J (1995) Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1237:176–182
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
El Maghraby, G.M. (2016). Ultradeformable Vesicles as Skin Drug Delivery Systems: Mechanisms of Action. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47862-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-47862-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47861-5
Online ISBN: 978-3-662-47862-2
eBook Packages: MedicineMedicine (R0)